Reported Earlier, Alumis Prices Its IPO Of 13.125M Shares At $16/Share, To Begin Trading Today
Portfolio Pulse from Benzinga Newsdesk
Alumis Inc. (NASDAQ: ALMS), a clinical-stage biopharmaceutical company, has priced its IPO of 13.125 million shares at $16 per share. Trading begins today on Nasdaq under the symbol 'ALMS'. The offering is expected to close on July 1, 2024.
June 28, 2024 | 7:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alumis Inc. has priced its IPO at $16 per share for 13.125 million shares, with trading starting today on Nasdaq. The offering is expected to close on July 1, 2024.
The IPO pricing and commencement of trading are significant events for Alumis Inc. The stock is likely to see increased interest and potential price movement as it begins trading on Nasdaq.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100